BACKGROUND: Although research has shown that early life exposure to household endotoxin protects against development of allergies, studies are less clear on the relationship between household endotoxin exposure and prevalence of wheezing and asthma. We assayed 2,552 house dust samples in a representative nationwide sam- ple to explore relationships between endotoxin exposures and risk factors for asthma, asthma symptoms, and medication use. METHODS: House dust was vacuum-sampled from five locations within homes and assayed for endotoxin. Health, demographic, and housing information was assessed through questionnaire and on-site evaluation of 2,456 residents of 831 homes selected to represent the demographics of the United States. RESULTS: Endotoxin concentration (EU/mg) and load (EU/m(2)) were highly correlated (r = 0.73-0.79). Geometric mean endotoxin concentrations were as follows (in EU/mg): bedroom floors, 35.3 (5th-95th percentile, 5.0-260); bedding, 18.7 (2.0-142); family room floors, 63.9 (11.5-331); sofas, 44.8 (6.4-240); and kitchen floors, 80.5 (9.8-512). Multivariate analysis demonstrated significant relationships between increasing endotoxin levels and diagnosed asthma, asthma symptoms in the past year, current use of asthma medications, and wheezing among residents of the homes. These relationships were strongest for bedroom floor and bedding dust and were observed in adults only. Modeling the joint effect of bedding and bedroom floor endotoxin on recent asthma symptoms yielded an adjusted odds ratio of 2.83 (95% confidence interval, 1.01-7.87). When stratified by allergy status, allergic subjects with higher endotoxin exposure were no more likely to have diagnosed asthma or asthma symptoms than nonallergic subjects. CONCLUSION: This study demonstrates that household endotoxin exposure is a significant risk factor for increased asthma prevalence.
BACKGROUND: Although research has shown that early life exposure to household endotoxin protects against development of allergies, studies are less clear on the relationship between household endotoxin exposure and prevalence of wheezing and asthma. We assayed 2,552 house dust samples in a representative nationwide sam- ple to explore relationships between endotoxin exposures and risk factors for asthma, asthma symptoms, and medication use. METHODS: House dust was vacuum-sampled from five locations within homes and assayed for endotoxin. Health, demographic, and housing information was assessed through questionnaire and on-site evaluation of 2,456 residents of 831 homes selected to represent the demographics of the United States. RESULTS: Endotoxin concentration (EU/mg) and load (EU/m(2)) were highly correlated (r = 0.73-0.79). Geometric mean endotoxin concentrations were as follows (in EU/mg): bedroom floors, 35.3 (5th-95th percentile, 5.0-260); bedding, 18.7 (2.0-142); family room floors, 63.9 (11.5-331); sofas, 44.8 (6.4-240); and kitchen floors, 80.5 (9.8-512). Multivariate analysis demonstrated significant relationships between increasing endotoxin levels and diagnosed asthma, asthma symptoms in the past year, current use of asthma medications, and wheezing among residents of the homes. These relationships were strongest for bedroom floor and bedding dust and were observed in adults only. Modeling the joint effect of bedding and bedroom floor endotoxin on recent asthma symptoms yielded an adjusted odds ratio of 2.83 (95% confidence interval, 1.01-7.87). When stratified by allergy status, allergic subjects with higher endotoxin exposure were no more likely to have diagnosed asthma or asthma symptoms than nonallergic subjects. CONCLUSION: This study demonstrates that household endotoxin exposure is a significant risk factor for increased asthma prevalence.
Authors: J N Kline; J D Cowden; G W Hunninghake; B C Schutte; J L Watt; C L Wohlford-Lenane; L S Powers; M P Jones; D A Schwartz Journal: Am J Respir Crit Care Med Date: 1999-07 Impact factor: 21.405
Authors: O Michel; J Kips; J Duchateau; F Vertongen; L Robert; H Collet; R Pauwels; R Sergysels Journal: Am J Respir Crit Care Med Date: 1996-12 Impact factor: 21.405
Authors: O Michel; A M Nagy; M Schroeven; J Duchateau; J Nève; P Fondu; R Sergysels Journal: Am J Respir Crit Care Med Date: 1997-10 Impact factor: 21.405
Authors: D C Deetz; P J Jagielo; T J Quinn; P S Thorne; S A Bleuer; D A Schwartz Journal: Am J Respir Crit Care Med Date: 1997-01 Impact factor: 21.405
Authors: Michelle L Hernandez; Margaret Herbst; John C Lay; Neil E Alexis; Willie June Brickey; Jenny P Y Ting; Haibo Zhou; David B Peden Journal: J Allergy Clin Immunol Date: 2012-07-04 Impact factor: 10.793
Authors: Daniel A Domer; Rebecca L Erickson; Joann M Petty; Valerie K Bergdall; Judy M Hickman-Davis Journal: J Am Assoc Lab Anim Sci Date: 2012-03 Impact factor: 1.232
Authors: Christopher D Pascoe; Aruni Jha; Sujata Basu; Thomas Mahood; Amy Lee; Sam Hinshaw; Reza Falsafi; Robert E W Hancock; Neeloffer Mookherjee; Andrew J Halayko Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-04-22 Impact factor: 5.464
Authors: S Semple; C Garden; M Coggins; K S Galea; P Whelan; H Cowie; A Sánchez-Jiménez; P S Thorne; J F Hurley; J G Ayres Journal: Indoor Air Date: 2011-11-09 Impact factor: 5.770
Authors: G S Whitehead; S Hussain; R Fannin; C S Trempus; C L Innes; S H Schurman; D N Cook; S Garantziotis Journal: Lung Date: 2020-02-14 Impact factor: 2.584